Communication with Patients with Hematological Malignancies in Argentina

  • Astrid Pavlovsky
  • Lourdes Bertolino
  • Victoria Patxot
  • Carolina Pavlovsky


Argentina is a country of immigrants and Buenos Aires, its capital city, one of the largest urban areas in the world. The country in which we live with all its cultural background together with the characteristics of the institution where we work, are important factors influencing our communication with patients.

Although the clinical information we give to our patients as well as the effort we take into communicating adequately are important therapeutic tools, in our country, there is no formal education on these topics. Most doctors learn to communicate with patients, guided by a model they choose and by personal intuition.

The time and effort dedicated to each patient regarded as an individual with all their personal characteristics, is of paramount importance throughout their new life situation facing a hematological diagnosis.

Chronic diseases with no necessary immediate treatment, others in which the overall survival can depend on the treatment compliance, and other cases needing aggressive chemotherapy with bad prognosis are some of the scenarios and challenges of communication with patients with hematological malignancies in Argentina.


Palliative Care Chronic Lymphocytic Leukemia Chronic Myeloid Leukemia Hematological Malignancy Chronic Myeloid Leukemia Patient 


  1. 1.
    Sanchez N, et al. Preferencias de comunicación y apoyo de pacientes oncológicos españoles. [Preferences of communication and support in Spanish oncology patients]. Psychooncology. 2005;2(1).Google Scholar
  2. 2.
    Isola L, et al. Medicina interna: la formación clínica inicial [Internal medicine: initial clinical education]. Buenos Aires: Editorial Losada; 2009.Google Scholar
  3. 3.
    Vidal y Benito M. La relación médico paciente [Doctor-patient relationship]. Buenos Aires: Editorial Lugar; 2010.Google Scholar
  4. 4.
    Gonzalez Baron M, et al. La relación médico paciente en oncología [Doctor-patient relationship in oncology]. Barcelona: Editorial ARS Médica; 2002.Google Scholar
  5. 5.
    Die Trill M. Psiconcologia [Psycho oncology]. Madrid: Editorial Ades; 2003.Google Scholar
  6. 6.
    Vidal y Benito M. Psiquiatría y psicología del paciente con cáncer [Psychiatry and psychology in cancer patients]. Buenos Aires: Editorial Polemos; 2008.Google Scholar
  7. 7.
    Bartram CR, de Klein A, Hagemeijer A, et al. Translocation of c-abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia. Nature. 1983;306:277–80.PubMedCrossRefGoogle Scholar
  8. 8.
    Druker BJ, Tamura S, Buchdunger E, et al. Effects of a selective inhibitor of the Abl-tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med. 1996;2:561–6.PubMedCrossRefGoogle Scholar
  9. 9.
    Partridge AH, Avorn J, Wang PS, et al. Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst. 2001;94:652–6.CrossRefGoogle Scholar
  10. 10.
    Noens L, van Lierde M-A, De Bock R, et al. Prevalence, determinants, and outcomes of non adherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study. Blood. 2009;113:5401–11.PubMedCrossRefGoogle Scholar
  11. 11.
    De Simeone G. El final de la vida: situaciones clínicas y cuestionamientos éticos [End of life: clinical situations and ethical questions]Google Scholar
  12. 12.
    Bayes R. Psicología del sufrimiento y de la muerte [Psychology of suffering and death]. Barcelona: Editorial Martinez Roca; 2001.Google Scholar
  13. 13.
    Gomez Sacho M. Como dar las malas noticias en medicina [How to give bad news in medicine]. Madrid: Editorial Aran; 2006.Google Scholar
  14. 14.
    Arranz P, et al. Intervención emocional en cuidados paliativos. Modelos y protocolos [Emotional intervention in palliative care. Models and protocols]. Barcelona: Editorial Ariel; 2005.Google Scholar
  15. 15.
    De Simone G. Final de Vida: situaciones clínicas y cuestionamientos éticos. Cuadernos del Programa Regional de Bioética OPS/OMS [End of life: clinical situations and questions. Journal of the Regional Bioethics Program PAHO/WHO]. Acta Bioethica. 2000;VI(1):47–62.Google Scholar
  16. 16.
    Gonzalez Baron M, Lacasta M, et al. El sindrome de agotamiento profesional en oncologia [Syndrome of professional exhaustion in oncology]. Madrid: Editorial Panamericana; 2008.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2013

Authors and Affiliations

  • Astrid Pavlovsky
    • 1
  • Lourdes Bertolino
    • 2
  • Victoria Patxot
    • 2
  • Carolina Pavlovsky
    • 3
  1. 1.Centro de Hematologia, Department of HematologyFUNDALEUBuenos AiresArgentina
  2. 2.FUNDALEU, Psicologia, CabaBuenos AiresArgentina
  3. 3.FUNDALEU, HematologyBuenos AiresArgentina

Personalised recommendations